{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:00:23Z","timestamp":1773658823246,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1130,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:p> <jats:italic>\n            \n\t\t\t\t\t\tAims<\/jats:italic>\u2007Frusemide is widely used in the treatment of acute pulmonary oedema, chronic congestive heart failure and, to a lesser degree, in the treatment of hypertension. Evidence suggests that frusemide exerts an anti\u2010vasoconstrictor effect independent of its diuretic properties. Since angiotensin II is a highly potent vasoconstrictor involved in the pathophysiology of these diseases, we have investigated the effect of frusemide on the contraction elicited by angiotensin II on human internal mammary artery (IMA) and saphenous vein (SV).<\/jats:p><jats:p> <jats:italic>\n            \n\t\t\t\t\t\tMethods\u2007Rings of IMA and SV were suspended for isometric tension recording in organ baths. Concentration\u2010response curves to angiotensin II were performed in the absence (control) or in the presence of frusemide (10<jats:sup>\u22126<\/jats:sup> to 10<jats:sup>\u22123<\/jats:sup>\u2003m\u200a). In addition, the effect of frusemide was evaluated after cyclooxygenase inhibition by indomethacin (10<jats:sup>\u22126<\/jats:sup>\u2003m\u200a) and was compared with those of the other loop diuretic bumetanide (10<jats:sup>\u22124<\/jats:sup><\/jats:italic>\u2003m\u200a).<\/jats:p><jats:p> <jats:italic>\n            \n\t\t\t\t\t\tResults\u2007Frusemide induced a concentration\u2010dependent decrease of the contraction elicited by angiotensin II on IMA and SV. On both vessels, the inhibitory effect on the maximal contraction to angiotensin II was significant with concentrations of frusemide from 10<jats:sup>\u22125<\/jats:sup> to 10<jats:sup>\u22123<\/jats:sup>\u2003m. Angiotensin II potency (pD<jats:sub>2<\/jats:sub>\u200a) was only reduced by 10<jats:sup>\u22123<\/jats:sup><\/jats:italic>\u2003m frusemide. The effect of frusemide was not altered in the presence of indomethacin. Bumetanide was less potent than frusemide in inhibiting angiotensin II\u2010induced contractions in both IMA and SV.<\/jats:p><jats:p> <jats:italic>\n            \n\t\t\t\t\t\tConclusions\u2007Frusemide, at concentrations in the therapeutic range (10<jats:sup>\u22125<\/jats:sup>\u2003m\u200a), inhibits angiotensin II\u2010induced contraction on human isolated IMA and SV. This inhibitory effect is cyclooxygenase independent and appears mediated, at least in part, by inhibition of Na<jats:sup>+<\/jats:sup>\/K<jats:sup>+<\/jats:sup>\/2Cl<jats:sup>\u2212<\/jats:sup><\/jats:italic> symport. Reduction in the vasoconstrictor effect of angiotensin II may be involved in the therapeutic efficacy of frusemide.<\/jats:p>","DOI":"10.1046\/j.1365-2125.1998.00820.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T04:32:57Z","timestamp":1047357177000},"page":"571-575","source":"Crossref","is-referenced-by-count":22,"title":["Frusemide inhibits angiotensin II\u2010induced contraction on human vascular smooth muscle"],"prefix":"10.1111","volume":"46","author":[{"given":"Fran\u00e7oise","family":"Stanke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Devillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Br\u00e9ant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Chavanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampierro>","family":"Bricca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germain","family":"Bessard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_5_2_2","unstructured":"JacksonEKDiuretics. In Goodman & Gilman\u2019sThe Pharmacological Basis of Therapeutics.Ninth Edition. McGraw\u2010Hill 1995 685715"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(87)90197-0"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199000153-00001"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/cs0650359","article-title":"The effects of captopril on the vascular responses to frusemide in man.","volume":"65","author":"Johnston GD","year":"1983","journal-title":"Clin Sci"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00553.x"},{"key":"e_1_2_5_7_2","first-page":"150","article-title":"Reactivity of human isolated internal mammary artery to constrictor and dilator agents.","volume":"80","author":"He GW","year":"1989","journal-title":"Circulation"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01458-1"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1972.tb09029.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90222-8"},{"key":"e_1_2_5_11_2","unstructured":"BiagiRW&BapatBNFrusemide in acute pulmonary oedema.Lancet1967;i:849"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197305242882102"},{"key":"e_1_2_5_13_2","first-page":"221","article-title":"The role of the kidney in the early nondiuretic action of furosemide to reduce left atrial pressure in the hypervolemic dog.","volume":"202","author":"Bourland WA","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.53.5.630"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112101"},{"key":"e_1_2_5_16_2","first-page":"102","article-title":"Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide.","volume":"246","author":"Lundergan CF","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.2.9609123"},{"key":"e_1_2_5_18_2","first-page":"209","article-title":"Vascular effects of loop diuretics: an in vivoand in vitro study in the rat.","volume":"349","author":"Stephan D","year":"1994","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"e_1_2_5_19_2","first-page":"1077","article-title":"Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine.","volume":"270","author":"Greenberg S","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_20_2","first-page":"9","article-title":"Effect of furosemide on the ionic composition of the arterial wall.","volume":"9","author":"Villamil MF","year":"1979","journal-title":"Life Sci"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(81)90150-3"},{"key":"e_1_2_5_22_2","first-page":"321","article-title":"Influence of furosemide on rubidium\u201086 uptake and alpha\u2010adrenergic responsiveness of arterial smooth muscle.","volume":"24","author":"Deth RC","year":"1987","journal-title":"Blood Vessels"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1990.tb00853.x"},{"key":"e_1_2_5_24_2","first-page":"769","article-title":"Angiotensin\u2010receptor signaling in cultured vascular smooth muscle cells.","volume":"250","author":"Smith JB","year":"1986","journal-title":"Am J Physiol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1016\/S0021-9258(18)42421-0","article-title":"The Na\/K\/2Cl Cotransporter is increased in hypertrophied vascular smooth muscle cells.","volume":"267","author":"Tseng H","year":"1992","journal-title":"J Biol Chem"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1998.00820.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1998.00820.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2125.1998.00820.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T22:29:32Z","timestamp":1698445772000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2125.1998.00820.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1046\/j.1365-2125.1998.00820.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2125.1998.00820.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}